Skip to main content

Table 3 Data of sensory conduction parameters for both patients with FM and controls

From: Enhanced sensory conduction in primary fibromyalgia: a case–control pilot study

Variable Mean ± SEM T value P value
Median SL Patients with FM 2.31 ± 0.04 − 2.578 .012*
Healthy controls 2.56 ± 0.11
Median SNAP Amp Patients with FM 67.36 ± 2.61 3.839 .000*
Healthy controls 49.25 ± 2.60
Median Sensory CV Patients with FM 62.02 ± 0.82 2.534 .013*
Healthy controls 47.96 ± 1.32
Ulnar SL Patients with FM 1.87 ± 0.03 − 2.999 .004*
Healthy controls 2.03 ± 0.05
Ulnar SNAP Amp Patients with FM 65.35 ± 2.40 3.417 .000*
Healthy controls 46.23 ± 2.97
Ulnar Sensory CV Patients with FM 57.61 ± 0.90 3.992 .000*
Healthy controls 50.57 ± 1.51
Sural SL Patients with FM 2.68 ± 0.05 − 1.496 .139
Healthy controls 2.69 ± 0.09
Sural SNAP Amp Patients with FM 20.78 ± 0.97 2.859 .005*
Healthy controls 15.21 ± 1.75
Sural Sensory CV Patients with FM 49.16 ± 1.03 2.260 .028*
Healthy controls 45.73 ± 1.11
  1. Amp Amplitude, CV Conduction Velocity, SNAP Sensory Nerve Action Potential, SL Sensory Latency, *Significant